Spitzer S A, Kaufman H, Koplovitz A, Topilsky M, Blum I
Chest. 1976 Jul;70(1):38-42. doi: 10.1378/chest.70.1.38.
Beclomethasone dipropionate aerosol at a dose of 100 mug four times a day was administered to 32 patients suffering from chronic perennial asthma. Twenty-three of these patients had previously received prolonged treatment with corticosteroids, causing various degrees of adrenal suppression in some patients. Almost complete recovery of adrenal function was observed within a period of six months in most patients. Treatment with beclomethasone dipropionate did not affect the hypothalamic-pituitary-adrenal axis in the other nine asthmatic patients who had not received prolonged corticosteroid therapy previously and who served as a control group.
对32例慢性常年性哮喘患者使用剂量为每日4次、每次100微克的二丙酸倍氯米松气雾剂。这些患者中有23例先前接受过长期的皮质类固醇治疗,部分患者出现了不同程度的肾上腺抑制。大多数患者在6个月内肾上腺功能几乎完全恢复。对于另一组未经长期皮质类固醇治疗、作为对照组的9例哮喘患者,使用二丙酸倍氯米松治疗并未影响下丘脑-垂体-肾上腺轴。